Risk of Diabetic Retinopathy in Patients With Type 2 Diabetes After SGLT‐2 Inhibitors: A Nationwide Population Cohort Study

Diabetic retinopathy (DR) accounts for 80% of cases of vision loss in patients with type 2 diabetes mellitus (T2DM). Interventional treatments are only indicated in advanced DR and are ineffective in some patients. Sodium–glucose cotransporter 2 inhibitors (SGLT2is) are used to attenuate T2DM‐associ...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical pharmacology and therapeutics 2024-01, Vol.115 (1), p.95-103
Hauptverfasser:	Huang, Shih‐Ting, Bair, Pei‐Jane, Chang, Shih‐Sheng, Kao, Yu‐Nong, Chen, San‐Ni, Wang, I‐Kang, Chiu, Chih‐Wei, Chang, Chi‐Tzung, Shih, Ying‐Hsiu, Li, Chi‐Yuan, Yu, Tung‐Min
Format:	Artikel
Sprache:	eng
Schlagworte:	Cohort Studies Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Diabetic Retinopathy - chemically induced Diabetic Retinopathy - complications Diabetic Retinopathy - epidemiology Dipeptidyl-Peptidase IV Inhibitors - adverse effects Humans Hypoglycemic Agents - adverse effects Retrospective Studies Sodium-Glucose Transporter 2 Inhibitors - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!